(RTTNews) - Harmony Biosciences Holdings, Inc. (HRMY), a biopharmaceutical company, on Monday announced that Senior Executive Vice President and Chief Operating Officer Peter Anastasiou will become President and CEO and join the Board, effective January 1, 2027.
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.